Larvol Delta - Biodexa-Announces-Activation-of-First-Clinical-Study-Site-for-Phase-3-Serenta-Trial-in-Familial-Adenomatous-Polyposis-FAP

eRapa (encapsulated rapamycin) - Biodexa Pharma

https://www.globenewswire.com/news-release/2025/06/25/3105070/0/en/Biodexa-Announces-Activation-of-First-Clinical-Study-Site-for-Phase-3-Serenta-Trial-in-Familial-Adenomatous-Polyposis-FAP.html

Jun 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next